Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Quest Diagnostics to Launch FDA-Cleared Alzheimer Blood Test and Multi-Biomarker Panel
10+ hour, 19+ min ago (428+ words) Clinical Lab Products...
Labcorp to Offer First FDA-Cleared Blood Test for Alzheimer Disease Pathology
10+ hour, 24+ min ago (157+ words) Aug 24, 2026 | Company News, Dementias & Alzheimer’s | Labcorp announced it will offer the Elecsys pTau-217 test following clearance by the Food and Drug Administration (FDA). Developed by Roche Diagnostics, the blood test aids in identifying amyloid pathology associated with Alzheimer disease in…...
FDA Clears Roche Blood Test for Alzheimer Disease Amyloid Pathology
10+ hour, 43+ min ago (243+ words) Aug 24, 2026 | Dementias & Alzheimer’s | The Food and Drug Administration (FDA) has cleared the Roche Elecsys Phospho-Tau (217P) Plasma (pTau217) blood test. The assay is intended to help clinicians identify amyloid pathology associated with Alzheimer disease in individuals 55 years and older who show signs,…...
GI-MAP Adds Cyclospora Guidance for Patients With Positive Test Results
3+ day, 10+ hour ago (220+ words) Aug 21, 2026 | Gastrointestinal Infections | GI–MAP Test, a service that provides access to the GI-MAP comprehensive stool test in the United States and Canada, has launched a guidance resource for customers whose test result detects the intestinal parasite Cyclospora. The company…...
Analysis Shows Blood RNA Test Improves Breast Cancer Screening Outcomes and Cost-Effectiveness
3+ day, 9+ hour ago (275+ words) Aug 21, 2026 | Breast | A health economic analysis published in the journal Clinical Breast Cancer reports that an investigational whole blood ribonucleic acid (RNA) test may complement existing breast imaging to improve health and cost outcomes. The study investigated the impacts of…...
Genetic Risk Score Identifies Hidden Type 1 Diabetes in MODY Referrals
3+ day, 9+ hour ago (198+ words) Aug 21, 2026 | Diabetes & Metabolic Diseases | Incorporating a genetic risk score into standard testing for a genetic form of diabetes could identify hidden type 1 diabetes in approximately one in five patients who receive a negative genetic test result, according to research from…...
FDA Clears Alzheimer’s Blood Test for Adults as Young as 40
3+ day, 10+ hour ago (394+ words) Aug 21, 2026 | Dementias & Alzheimer’s, Mass Spectrometry | The Food and Drug Administration (FDA) cleared C2N Diagnostics’ PrecivityAD2 blood test for use in adults as young as 40 who are experiencing signs of cognitive impairment. This clearance makes it the first FDA-cleared Alzheimer’s blood test available…...
Researchers Develop AI Framework to Increase Pathology Diagnostic Reliability
4+ day, 9+ hour ago (220+ words) Aug 20, 2026 | Anatomic Pathology, Cancer, Digital Pathology | A research team at The Hong Kong Polytechnic University developed an integrated artificial intelligence (AI) framework named TRUECAM to improve the reliability of pathology AI used in cancer diagnosis. The framework, which stands for…...
Patients Are Seeing Their Lab Results Before Their Doctors. Do They Understand Them?
4+ day, 9+ hour ago (286+ words) Aug 20, 2026 | Education, Information Technology | More than two-thirds of adults in the United States now view their medical test results through online portals before hearing from a healthcare provider, according to a study led by researchers at NYU School of Global…...
cfDNA Screening Shows High Accuracy for Fetal Risk Without Partner Testing
4+ day, 9+ hour ago (351+ words) Aug 20, 2026 | Prenatal Testing | BillionToOne announced the publication of a multi-site study in The Green Journal evaluating the performance of cell-free DNA (cfDNA) testing for recessive conditions in a large, general-risk pregnancy population. The study provides evidence supporting the routine use…...